This study shows that the General Symptom Questionnaire-30 (GSQ-30) is a valid and reliable self-report instrument that clinicians and researchers could use to assess the multi-system symptom burden and response to treatment among patients with acute and post-treatment Lyme disease.
Lyme Disease Research
Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease
Molecular testing of serial blood specimens from patients with early Lyme disease during antibiotic treatment reveals changing Borrelia burgdorferi genotypes
This pilot study showed a direct molecular Lyme disease diagnostic test could be used to identify and genotype Borrelia burgdorferi during antibiotic treatment in early Lyme disease patients. Findings suggest that the host immune system or differential antibiotic susceptibility might have played a role in the observed genotypic shift.